BioCentury | Jul 29, 2020
Finance

With €27M at launch, Vico revives Prosensa oligonucleotide programs, aims to edit RNA for Rett

...round led by LSP. Joining that firm were co-leader Kurma Partners as well as Pontifax, Droia...
...were the first to join the syndicate. Joining them subsequently were Polaris, Pureos, and the Droia...
...partner at Polaris and CEO of Camp4 Therapeutics Corp.; Dochez is managing partner at the Droia...
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...Mission BioCapital, INKEF Capital and the Dementia Discovery Fund led the round. Also participating were Droia...
...which invested via its LS Polaris Innovation Fund; INKEF’s Roel Bulthuis; DDF’s Jonathan Behr; and Droia’s...
...raised: $50.5 million Investors: LS Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Droia...
BioCentury | Apr 23, 2020
Finance

RNA epigenetic cancer company Accent adds $63M in series B round

...round. New investors GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment and Droia...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...tumor vasculature, marking the second company seeded by oncology-focused Droia Ventures in as many weeks. Droia...
...to modulate function of the immune cells that are directly stimulating or repressing antitumor immunity. “Droia...
...than what everyone else was doing,” said Dochez, who is also a managing partner at Droia...
BioCentury | Feb 12, 2020
Emerging Company Profile

Volastra raises $12M seed led by Polaris to shut down metastasis

...driver of cancer metastasis. Polaris Partners led the seed round on Tuesday with participation from Droia...
...A, then we can pursue a lot of these targets in parallel,” he said. Schulman, Droia’s...
...Center Corporate partners: N/A Number of employees: 3 Funds raised: $12 million Investors: Polaris Partners, Droia...
BioCentury | Jan 11, 2020
Financial News

Pact’s $75M series C gives Vida’s Kite alumni long-sought stab at personalized cell therapy

...rounds were led by GV; its other investors are Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA...
BioCentury | Oct 15, 2019
Finance

Cyteir synthetic lethality compound prompts Novo to lead $40M investment

...submitting an IND for its next candidate before the company’s next offering. Existing investors Venrock, DROIA...
BioCentury | Oct 11, 2019
Product Development

What’s next for neoantigens

...rounds were led by GV, and had participation from Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Management tracks: R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more

...In June, Frontier raised $67 million in a series A round led by Deerfield Management, Droia...
BioCentury | Jun 25, 2019
Finance

Frontier aims for previously unreachable ‘hot spot’ targets with $67M series A

...relatively early.” Luke Evnin, MPM Joining MPM in the round were co-leaders Deerfield Management and Droia...
...stage investors typically have. DCVC, also known as Data Collective, brought technology expertise, while Europe-based Droia...
Items per page:
1 - 10 of 25
BioCentury | Jul 29, 2020
Finance

With €27M at launch, Vico revives Prosensa oligonucleotide programs, aims to edit RNA for Rett

...round led by LSP. Joining that firm were co-leader Kurma Partners as well as Pontifax, Droia...
...were the first to join the syndicate. Joining them subsequently were Polaris, Pureos, and the Droia...
...partner at Polaris and CEO of Camp4 Therapeutics Corp.; Dochez is managing partner at the Droia...
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...Mission BioCapital, INKEF Capital and the Dementia Discovery Fund led the round. Also participating were Droia...
...which invested via its LS Polaris Innovation Fund; INKEF’s Roel Bulthuis; DDF’s Jonathan Behr; and Droia’s...
...raised: $50.5 million Investors: LS Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Droia...
BioCentury | Apr 23, 2020
Finance

RNA epigenetic cancer company Accent adds $63M in series B round

...round. New investors GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment and Droia...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...tumor vasculature, marking the second company seeded by oncology-focused Droia Ventures in as many weeks. Droia...
...to modulate function of the immune cells that are directly stimulating or repressing antitumor immunity. “Droia...
...than what everyone else was doing,” said Dochez, who is also a managing partner at Droia...
BioCentury | Feb 12, 2020
Emerging Company Profile

Volastra raises $12M seed led by Polaris to shut down metastasis

...driver of cancer metastasis. Polaris Partners led the seed round on Tuesday with participation from Droia...
...A, then we can pursue a lot of these targets in parallel,” he said. Schulman, Droia’s...
...Center Corporate partners: N/A Number of employees: 3 Funds raised: $12 million Investors: Polaris Partners, Droia...
BioCentury | Jan 11, 2020
Financial News

Pact’s $75M series C gives Vida’s Kite alumni long-sought stab at personalized cell therapy

...rounds were led by GV; its other investors are Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA...
BioCentury | Oct 15, 2019
Finance

Cyteir synthetic lethality compound prompts Novo to lead $40M investment

...submitting an IND for its next candidate before the company’s next offering. Existing investors Venrock, DROIA...
BioCentury | Oct 11, 2019
Product Development

What’s next for neoantigens

...rounds were led by GV, and had participation from Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Management tracks: R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more

...In June, Frontier raised $67 million in a series A round led by Deerfield Management, Droia...
BioCentury | Jun 25, 2019
Finance

Frontier aims for previously unreachable ‘hot spot’ targets with $67M series A

...relatively early.” Luke Evnin, MPM Joining MPM in the round were co-leaders Deerfield Management and Droia...
...stage investors typically have. DCVC, also known as Data Collective, brought technology expertise, while Europe-based Droia...
Items per page:
1 - 10 of 25